vspВопросы современной педиатрииCurrent Pediatrics1682-55271682-5535Издательство «ПедиатрЪ»10.15690/vsp.v21i5.2451vsp-3029Research ArticleОБЗОРЫ ЛИТЕРАТУРЫLITERATURE REVIEWФолликулярный кератоз у подростков: особенности диагностики и косметологические аспекты терапииFollicular Keratosis in Adolescents: Diagnostic Features and Cosmetological Aspects of Therapyhttps://orcid.org/0000-0002-8813-9132ИконниковаЕ. В.IkonnikovaEvgenia V.

Иконникова Евгения Владимировна - доцент кафедры дерматовенерологии и косметологии Центральной ГМА Управления делами Президента РФ.

121359, Москва, ул. Маршала Тимошенко, 19, стр. 1А,  тел.: +7 (499) 140-18-76

Moscow

evikonnikova@bk.ruhttps://orcid.org/0000-0002-5044-5265КругловаЛ. С.KruglovaLarisa S.

Москва

Moscow

ЦГМА Управления делами Президента РФ; Институт пластической хирургии и косметологииРоссияCentral State Medical Academy of Department of Presidential Affairs; Institute of Plastic Surgery and CosmetologyRussian Federation202207112022215342346Copyright © Иконникова Е.В., Круглова Л.С., 20222022Иконникова Е.В., Круглова Л.С.Ikonnikova E.V., Kruglova L.S.Данная работа распространяется под лицензией Creative Commons Attribution 4.0.This work is licensed under a Creative Commons Attribution 4.0 License.https://vsp.spr-journal.ru/jour/article/view/3029

Фолликулярный кератоз (ФК) является одним из наиболее распространенных дерматологических заболеваний детского возраста. Манифестируя в раннем детстве, ФК часто прогрессирует, вследствие чего симптомы болезни наиболее выражены в пубертатном периоде. Поражается преимущественно кожа проксимальных разгибательных отделов верхних и нижних конечностей, реже — кожа области щек, спины и ягодиц. ФК представляет собой исключительно косметологический дефект, который оказывает значительное влияние на самооценку и эмоциональное состояние подростков, вплоть до развития тяжелого депрессивного синдрома и навязчивых состояний, сопровождающихся патомимией. ФК может быть связан с другими нозологиями — атопическим дерматитом, вульгарным ихтиозом, ожирением, сахарным диабетом, а также сопровождать синдромы Дауна и Нунан. С возрастом возможно спонтанное улучшение. В целях сглаживания проявлений болезни применяются топическая терапия смягчающими, кератолитическими, противовоспалительными средствами, а также различные виды лазерной и фототерапии. В статье приводятся основные сведения об этиологии, патогенезе и лечении ФК с описанием клинического случая из практики.

Follicular keratosis (FK) is one of the most common dermatological diseases in children. FK manifests usually in early childhood and worsen frequently, thus, symptoms are more prominent during puberty. The skin of proximal extensors of upper and lower limbs is mainly affected, while skin of cheeks, back and buttocks is affected more rarely. FK is just a cosmetic defect which significantly affects adolescents’ self-esteem and emotional state up to the development of severe depressive syndrome and obsessive conditions accompanied by pathomimia. FK can be associated with other nosologies such as: atopic dermatitis, vulgar ichthyosis, obesity, diabetes mellitus, and even aggravate Down and Noonan syndromes. Spontaneous improvement is still possible with age. We can use topical therapy with emollient, keratolytic, anti-inflammatory drugs, as well as various types of laser and phototherapy to alleviate the disease symptoms. This article provides basic information on etiology, pathogenesis, and treatment of FK with clinical case description.

подросткифолликулярный кератозлазерная терапиятопическая терапияadolescentsfollicular keratosislaser therapytopical therapyОтсутствуетNot specifiedReferencesEhsani A, Namazi MR, Barikbin B, Nazemi MJ. Unilaterally generalized keratosis pilaris. J Eur Acad Dermatol Venereol. 2003;17(3):361–362. doi: https://doi.org/10.1046/j.1468-3083.2003.00792_10.xEhsani A, Namazi MR, Barikbin B, Nazemi MJ. Unilaterally generalized keratosis pilaris. J Eur Acad Dermatol Venereol. 2003;17(3):361–362. doi: https://doi.org/10.1046/j.1468-3083.2003.00792_10.xTian Y, Li XX, Zhang JJ, et al. Clinical outcomes and 5-year follow-up results of keratosis pilaris treated by a high concentration of glycolic acid. World J Clin Cases. 2021;9(18):4681–4689. doi: https://doi.org/10.12998/wjcc.v9.i18.4681Tian Y, Li XX, Zhang JJ, et al. Clinical outcomes and 5-year follow-up results of keratosis pilaris treated by a high concentration of glycolic acid. World J Clin Cases. 2021;9(18):4681–4689. doi: https://doi.org/10.12998/wjcc.v9.i18.4681Kootiratrakarn T, Kampirapap K, Chunhasewee C. Epidermal permeability barrier in the treatment of keratosis pilaris. Dermatol Res Pract. 2015;2015:205012. doi: https://doi.org/10.1155/2015/205012Kootiratrakarn T, Kampirapap K, Chunhasewee C. Epidermal permeability barrier in the treatment of keratosis pilaris. Dermatol Res Pract. 2015;2015:205012. doi: https://doi.org/10.1155/2015/205012Reddy S, Brahmbhatt H. A narrative review on the role of acids, steroids, and kinase inhibitors in the treatment of keratosis pilaris. Cureus. 2021;13(10):18917. doi: https://doi.org/10.7759/cureus.18917Reddy S, Brahmbhatt H. A narrative review on the role of acids, steroids, and kinase inhibitors in the treatment of keratosis pilaris. Cureus. 2021;13(10):18917. doi: https://doi.org/10.7759/cureus.18917Hosking AM, Elsensohn A, Makdisi J, et al. Keratosis pilaris rubra with mucin deposition. J Cutan Pathol. 2018;45(12):958–961. doi: https://doi.org/10.1111/cup.13365Hosking AM, Elsensohn A, Makdisi J, et al. Keratosis pilaris rubra with mucin deposition. J Cutan Pathol. 2018;45(12):958–961. doi: https://doi.org/10.1111/cup.13365Liu F, Yang Y, Zheng Y, et al. Mutation and expression of ABCA12 in keratosis pilaris and nevus comedonicus. Mol Med Rep. 2018;18(3): 3153–3158. doi: https://doi.org/10.3892/mmr.2018.9342Liu F, Yang Y, Zheng Y, et al. Mutation and expression of ABCA12 in keratosis pilaris and nevus comedonicus. Mol Med Rep. 2018;18(3): 3153–3158. doi: https://doi.org/10.3892/mmr.2018.9342Fenner J, Silverberg NB. Skin diseases associated with atopic dermatitis. Clin Dermatol. 2018;36(5):631–640. doi: https://doi.org/10.1016/j.clindermatol.2018.05.004Fenner J, Silverberg NB. Skin diseases associated with atopic dermatitis. Clin Dermatol. 2018;36(5):631–640. doi: https://doi.org/10.1016/j.clindermatol.2018.05.004Poskitt L, Wilkinson JD. Natural history of keratosis pilaris. Br J Dermatol. 1994;130(6):711–713. doi: https://doi.org/10.1111/j.1365-2133.1994.tb03406.xPoskitt L, Wilkinson JD. Natural history of keratosis pilaris. Br J Dermatol. 1994;130(6):711–713. doi: https://doi.org/10.1111/j.1365-2133.1994.tb03406.xArnold AW, Buechner SA. Keratosis pilaris and keratosis pilaris atrophicans faciei. J Dtsch Dermatol Ges. 2006;4(4):319–323. doi: https://doi.org/10.1111/j.1610-0387.2006.05933.xArnold AW, Buechner SA. Keratosis pilaris and keratosis pilaris atrophicans faciei. J Dtsch Dermatol Ges. 2006;4(4):319–323. doi: https://doi.org/10.1111/j.1610-0387.2006.05933.xGruber R, Sugarman JL, Crumrine D, et al. Sebaceous gland, hair shaft, and epidermal barrier abnormalities in keratosis pilaris with and without filaggrin deficiency. Am J Pathol. 2015;185(4): 1012–1021. doi: https://doi.org/10.1016/j.ajpath.2014.12.012Gruber R, Sugarman JL, Crumrine D, et al. Sebaceous gland, hair shaft, and epidermal barrier abnormalities in keratosis pilaris with and without filaggrin deficiency. Am J Pathol. 2015;185(4): 1012–1021. doi: https://doi.org/10.1016/j.ajpath.2014.12.012Cohen L, Seminario-Vidal L, Lockey RF. Dermatologic problems commonly seen by the allergist/immunologist. J Allergy Clin Immunol Pract. 2020;8(1):102–112. doi: https://doi.org/10.1016/j.jaip.2019.07.019Cohen L, Seminario-Vidal L, Lockey RF. Dermatologic problems commonly seen by the allergist/immunologist. J Allergy Clin Immunol Pract. 2020;8(1):102–112. doi: https://doi.org/10.1016/j.jaip.2019.07.019Фаассен М.В. RAS-патии: синдром Нунан и другие родственные заболевания. Обзор литературы // Проблемы эндокринологии. — 2014. — Т. 60. — № 6. — С. 45–52. — doi: https://doi.org/10.14341/probl201460645-52Faassen MV. RAS-pathies: Noonan syndrome and other related diseases. The literature review. Problems of Endocrinology. 2014;60(6):45–52. (In Russ). doi: https://doi.org/10.14341/probl201460645-52Nazarenko SA, Ostroverkhova NV, Vasiljeva EO, et al. Keratosis pilaris and ulerythema ophryogenes associated with an 18p deletion caused by a Y/18 translocation. Am J Med Genet. 1999;85(2):179–182. doi: https://doi.org/10.1002/(SICI)10968628(19990716)85:2<179::AID-AJMG14>3.0.CO;2-RNazarenko SA, Ostroverkhova NV, Vasiljeva EO, et al. Keratosis pilaris and ulerythema ophryogenes associated with an 18p deletion caused by a Y/18 translocation. Am J Med Genet. 1999;85(2):179–182. doi: https://doi.org/10.1002/(SICI)10968628(19990716)85:2<179::AID-AJMG14>3.0.CO;2-RThomas M, Khopkar US. Keratosis pilaris revisited: is it more than just a follicular keratosis? Int J Trichology. 2012;4(4):255–258. doi: https://doi.org/10.4103/0974-7753.111215Thomas M, Khopkar US. Keratosis pilaris revisited: is it more than just a follicular keratosis? Int J Trichology. 2012;4(4):255–258. doi: https://doi.org/10.4103/0974-7753.111215Васечкина Л.И., Тюрина Т.К., Шестерикова В.В., Шестериков Н.В. Атопический дерматит, «аллергический синдром» и проблемы профилактики аллергии у детей // Аллергология и иммунология в педиатрии. — 2010. — № 2. — С. 25–29. — doi: https://doi.org/10.24411/2500-1175-2010-00014Vasechkina LI, Tyurina TK, Shesterikova VV, Shesterikov NV. Atopic dermatitis, “allergic syndrome” and problems of allergy prevention in children. Allergology and Immunology in Pediatrics. 2010;(2):25–29. (In Russ). doi: https://doi.org/10.24411/2500-1175-2010-00014Barth JH, Wojnarowska F, Dawber RP. Is keratosis pilaris another androgen-dependent dermatosis? Clin Exp Dermatol. 1988;13(4): 240–241. doi: https://doi.org/10.1111/j.1365-2230.1988.tb00688.xBarth JH, Wojnarowska F, Dawber RP. Is keratosis pilaris another androgen-dependent dermatosis? Clin Exp Dermatol. 1988;13(4): 240–241. doi: https://doi.org/10.1111/j.1365-2230.1988.tb00688.xJackson JB, Touma SC, Norton AB. Keratosis pilaris in pregnancy: an unrecognized dematosis of pregnancy? W V Med J. 2004;100(1):26–28.Jackson JB, Touma SC, Norton AB. Keratosis pilaris in pregnancy: an unrecognized dematosis of pregnancy? W V Med J. 2004;100(1):26–28.Plascencia Gomez A, Vega Memije ME, Torres Tamayo M, Rodriguez Carreon AA. Skin disorders in overweight and obese patients and their relationship with insulin. Actas Dermosifiliogr. 2014;105(2): 178–185. doi: https://doi.org/10.1016/j.ad.2013.09.008Plascencia Gomez A, Vega Memije ME, Torres Tamayo M, Rodriguez Carreon AA. Skin disorders in overweight and obese patients and their relationship with insulin. Actas Dermosifiliogr. 2014;105(2): 178–185. doi: https://doi.org/10.1016/j.ad.2013.09.008Thai K, Sinclair RD. Keratosis pilaris and hereditary koilonychia without monilethrix. J Am Acad Dermatol. 2001;45(4):627–629. doi: https://doi.org/10.1067/mjd.2001.116225Thai K, Sinclair RD. Keratosis pilaris and hereditary koilonychia without monilethrix. J Am Acad Dermatol. 2001;45(4):627–629. doi: https://doi.org/10.1067/mjd.2001.116225Lee D, Yamasaki K, Rudsil J, et al. Sebocytes express functional cathelicidin antimicrobial peptides and can act to kill propionibacterium acnes. J Invest Dermatol. 2008;128(7):1863–1866. doi: https://doi.org/10.1038/sj.jid.5701235Lee D, Yamasaki K, Rudsil J, et al. Sebocytes express functional cathelicidin antimicrobial peptides and can act to kill propionibacterium acnes. J Invest Dermatol. 2008;128(7):1863–1866. doi: https://doi.org/10.1038/sj.jid.5701235Sonthalia S, Bhatia J, Thomas M. Dermoscopy of keratosis pilaris. Indian Dermatol Online J. 2019;10(5):613–614. doi: https://doi.org/10.4103/idoj.IDOJ_279_18Sonthalia S, Bhatia J, Thomas M. Dermoscopy of keratosis pilaris. Indian Dermatol Online J. 2019;10(5):613–614. doi: https://doi.org/10.4103/idoj.IDOJ_279_18Pennycook KB, McCready TA. Keratosis Pilaris. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2022.Pennycook KB, McCready TA. Keratosis Pilaris. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2022.Круглова Л.С., Мордовцева В.В., Жукова О.В., Серов Д.Н. Комбинация кальципотриола и бетаметазона в лечении псориаза // Клиническая дерматология и венерология. — 2014. — Т. 12. — № 6. — С. 54–63.Kruglova LS, Mordovtseva VV, Zhukova OV, Serov DN. Combination of calcipotriol and betamethasone in psoriasis treatment. Klinicheskaya Dermatologiya i Venerologiya. 2014;12(6):54–63. (In Russ).Jiang L, Tu P, Tan YH, et al. Clinical efficacy of 810 nm semiconductor laser in the treatment of keratosis pilaris. Zhonghua Yixue Meixu Meirong Zazhi. 2015;21:226–228.Jiang L, Tu P, Tan YH, et al. Clinical efficacy of 810 nm semiconductor laser in the treatment of keratosis pilaris. Zhonghua Yixue Meixu Meirong Zazhi. 2015;21:226–228.Vachiramon V, Anusaksathien P, Kanokrungsee S, Chanprapaph K. Fractional carbon dioxide laser for keratosis pilaris: a single-blind, randomized, comparative study. Biomed Res Int. 2016;2016: 1928540. doi: https://doi.org/10.1155/2016/1928540Vachiramon V, Anusaksathien P, Kanokrungsee S, Chanprapaph K. Fractional carbon dioxide laser for keratosis pilaris: a single-blind, randomized, comparative study. Biomed Res Int. 2016;2016: 1928540. doi: https://doi.org/10.1155/2016/1928540Gerbig AW. Treating keratosis pilaris. J Am Acad Dermatol. 2002;47(3):457. doi: https://doi.org/10.1067/mjd.2002.122733Gerbig AW. Treating keratosis pilaris. J Am Acad Dermatol. 2002;47(3):457. doi: https://doi.org/10.1067/mjd.2002.122733Reserva J, Champlain A, Soon SL, Tung R. Chemical peels: indications and special considerations for the male patient. Dermatol Surg. 2017;43(Suppl 2):163–173. doi: https://doi.org/10.1097/DSS.0000000000001281Reserva J, Champlain A, Soon SL, Tung R. Chemical peels: indications and special considerations for the male patient. Dermatol Surg. 2017;43(Suppl 2):163–173. doi: https://doi.org/10.1097/DSS.0000000000001281Lee SJ, Choi MJ, Zheng Z, et al. Combination of 595-nm pulsed dye laser, long-pulsed 755-nm alexandrite laser, and microdermabrasion treatment for keratosis pilaris: retrospective analysis of 26 Korean patients. J Cosmet Laser Ther. 2013;15(3):150–154. doi: https://doi.org/10.3109/14764172.2013.769276Lee SJ, Choi MJ, Zheng Z, et al. Combination of 595-nm pulsed dye laser, long-pulsed 755-nm alexandrite laser, and microdermabrasion treatment for keratosis pilaris: retrospective analysis of 26 Korean patients. J Cosmet Laser Ther. 2013;15(3):150–154. doi: https://doi.org/10.3109/14764172.2013.769276Saelim P, Pongprutthipan M, Pootongkam S, et al. Long-pulsed 1064-nm Nd:YAG laser significantly improves keratosis pilaris: a randomized, evaluator-blind study. J Dermatolog Treat. 2013;24(4): 318–322. doi: https://doi.org/10.3109/09546634.2012.660518Saelim P, Pongprutthipan M, Pootongkam S, et al. Long-pulsed 1064-nm Nd:YAG laser significantly improves keratosis pilaris: a randomized, evaluator-blind study. J Dermatolog Treat. 2013;24(4): 318–322. doi: https://doi.org/10.3109/09546634.2012.660518Maitriwong P, Tangkijngamvong N, Asawanonda P. Intense pulsed-light therapy significantly improves keratosis pilaris: a randomized, double-blind, sham irradiation-controlled trial. J Clin Aesthet Dermatol. 2019;12(10):53–57.Maitriwong P, Tangkijngamvong N, Asawanonda P. Intense pulsed-light therapy significantly improves keratosis pilaris: a randomized, double-blind, sham irradiation-controlled trial. J Clin Aesthet Dermatol. 2019;12(10):53–57.Hosking AM, Elsensohn A, Makdisi J, et al. Keratosis pilaris rubra with mucin deposition. J Cutan Pathol. 2018;45(12):958–961. doi: https://doi.org/10.1111/cup.13365Hosking AM, Elsensohn A, Makdisi J, et al. Keratosis pilaris rubra with mucin deposition. J Cutan Pathol. 2018;45(12):958–961. doi: https://doi.org/10.1111/cup.13365Marqueling AL, Gilliam AE, Prendiville J, et al. Keratosis pilaris rubra: a common but underrecognized condition. Arch Dermatol. 2006;142(12):1611–1616. doi: https://doi.org/10.1001/archderm.142.12.1611Marqueling AL, Gilliam AE, Prendiville J, et al. Keratosis pilaris rubra: a common but underrecognized condition. Arch Dermatol. 2006;142(12):1611–1616. doi: https://doi.org/10.1001/archderm.142.12.1611

The authors declare that there are no conflicts of interest present.